On 14 October, the Australian Technical Advisory Group on Immunisation (ATAGI) published its fourth annual statement in immunisation. The statement highlights the key successes, trends and challenges in the use of vaccines and control of vaccine preventable diseases in Australia in 2024, and includes advice to address key issues for 2025.

The report identifies emerging and re-emerging vaccine-preventable diseases of particular concern, including:

  • mpox
  • pertussis (whooping cough).

The report is available to read in full on the Australian Department of Health, Disability and Ageing website. 

MVEC:麻疹
MVEC: Mpox
MVEC: Pertussis (whooping cough) 

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。

分享这个